Lv1
40 积分 2023-12-04 加入
Chemotherapy de-escalation using an 18F-FDG-PET-based pathological response-adapted strategy in patients with HER2-positive early breast cancer (PHERGain): a multicentre, randomised, open-label, non-comparative, phase 2 trial
3天前
已完结
Response to neoadjuvant chemotherapy for breast cancer judged by PERCIST – multicenter study in Japan
3个月前
已完结
Increased 68Ga-FAPI Uptake in Neurofibromatosis in a Patient With Pleomorphic Rhabdomyosarcoma
4个月前
已完结
68Ga-FAPI PET/CT as an Alternative to18F-FDG PET/CT in the Imaging of Invasive Lobular Breast Carcinoma
4个月前
已完结
Simplified algorithm for genetic subtyping in diffuse large B-cell lymphoma
4个月前
已完结
PET/CT Biomarkers Enable Risk Stratification of Patients with Relapsed/Refractory Diffuse Large B-cell Lymphoma Enrolled in the LOTIS-2 Clinical Trial
5个月前
已完结
Baseline PET radiomics outperform the IPI risk score for prediction of outcome in diffuse large B-cell lymphoma
5个月前
已完结
Practical PERCIST: A Simplified Guide to PET Response Criteria in Solid Tumors 1.0
11个月前
已完结
Therapeutic potential of [177Lu]Lu-DOTAGA-FAPi dimers in metastatic breast cancer patients with limited treatment options: efficacy and safety assessment
11个月前
已完结
Non-oncologic incidental uptake on FAPI PET/CT imaging
11个月前
已完结
皖公网安备34019202002308
